I am glad that the mild to moderate trial data PR is coming out on Tuesday, rather than Monday, as Astrazenca's vaccine phase 1 trial data coming out on Monday will likely dominate the press. Leronlimab can own Tuesday!

I think that NP said at the end of tonight's talk that we won't hear about the severe clinical trial until the following week; that is still July and I can live with that.